524 related articles for article (PubMed ID: 18821135)
1. Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.
Khatib R; Johnson LB; Sharma M; Fakih MG; Ganga R; Riederer K
Scand J Infect Dis; 2009; 41(1):4-9. PubMed ID: 18821135
[TBL] [Abstract][Full Text] [Related]
2. Persistent Staphylococcus aureus bacteremia: an analysis of risk factors and outcomes.
Hawkins C; Huang J; Jin N; Noskin GA; Zembower TR; Bolon M
Arch Intern Med; 2007 Sep; 167(17):1861-7. PubMed ID: 17893307
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
Laupland KB; Ross T; Gregson DB
J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
[TBL] [Abstract][Full Text] [Related]
4. Feedback to clinicians on preventable factors can reduce hospital onset Staphylococcus aureus bacteraemia rates.
Kok J; O'Sullivan MV; Gilbert GL
J Hosp Infect; 2011 Oct; 79(2):108-14. PubMed ID: 21741724
[TBL] [Abstract][Full Text] [Related]
5. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.
Jang HC; Kim SH; Kim KH; Kim CJ; Lee S; Song KH; Jeon JH; Park WB; Kim HB; Park SW; Kim NJ; Kim EC; Oh MD; Choe KW
Clin Infect Dis; 2009 Aug; 49(3):395-401. PubMed ID: 19569970
[TBL] [Abstract][Full Text] [Related]
6. Persistence in Staphylococcus aureus bacteremia: incidence, characteristics of patients and outcome.
Khatib R; Johnson LB; Fakih MG; Riederer K; Khosrovaneh A; Shamse Tabriz M; Sharma M; Saeed S
Scand J Infect Dis; 2006; 38(1):7-14. PubMed ID: 16338832
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular epidemiology of nursing home-associated Staphylococcus aureus bacteremia.
Lesse AJ; Mylotte JM
Am J Infect Control; 2006 Dec; 34(10):642-50. PubMed ID: 17161739
[TBL] [Abstract][Full Text] [Related]
8. Staphylococcus aureus bacteremia.
Jensen AG
Dan Med Bull; 2003 Nov; 50(4):423-38. PubMed ID: 14694855
[TBL] [Abstract][Full Text] [Related]
9. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance.
Chang FY; MacDonald BB; Peacock JE; Musher DM; Triplett P; Mylotte JM; O'Donnell A; Wagener MM; Yu VL
Medicine (Baltimore); 2003 Sep; 82(5):322-32. PubMed ID: 14530781
[TBL] [Abstract][Full Text] [Related]
10. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre.
Kaech C; Elzi L; Sendi P; Frei R; Laifer G; Bassetti S; Fluckiger U
Clin Microbiol Infect; 2006 Apr; 12(4):345-52. PubMed ID: 16524411
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan.
Lin SH; Liao WH; Lai CC; Liao CH; Tan CK; Wang CY; Huang YT; Hsueh PR
J Antimicrob Chemother; 2010 Aug; 65(8):1792-8. PubMed ID: 20511366
[TBL] [Abstract][Full Text] [Related]
12. Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin.
Yoon YK; Kim JY; Park DW; Sohn JW; Kim MJ
J Antimicrob Chemother; 2010 May; 65(5):1015-8. PubMed ID: 20200036
[TBL] [Abstract][Full Text] [Related]
13. Predisposing factors, disease progression and outcome in 430 prospectively followed patients of healthcare- and community-associated Staphylococcus aureus bacteraemia.
Forsblom E; Ruotsalainen E; Mölkänen T; Ollgren J; Lyytikäinen O; Järvinen A
J Hosp Infect; 2011 Jun; 78(2):102-7. PubMed ID: 21511366
[TBL] [Abstract][Full Text] [Related]
14. Methicillin-resistant Staphylococcus aureus bacteremia: epidemiology, outcome, and laboratory characteristics in a tertiary referral center in the UK.
Lewis T; Chaudhry R; Nightingale P; Lambert P; Das I
Int J Infect Dis; 2011 Feb; 15(2):e131-5. PubMed ID: 21134776
[TBL] [Abstract][Full Text] [Related]
15. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
Soriano A; Marco F; Martínez JA; Pisos E; Almela M; Dimova VP; Alamo D; Ortega M; Lopez J; Mensa J
Clin Infect Dis; 2008 Jan; 46(2):193-200. PubMed ID: 18171250
[TBL] [Abstract][Full Text] [Related]
16. Audit of the management of Staphylococcus aureus bloodstream infection: gaps to be plugged.
Barry A; McNicholas S; Smyth E; Humphreys H; Fitzpatrick F
J Hosp Infect; 2010 Nov; 76(3):272-3. PubMed ID: 20435374
[No Abstract] [Full Text] [Related]
17. Diagnosis and management of Staphylococcus aureus bacteraemia.
Mitchell DH; Howden BP
Intern Med J; 2005 Dec; 35 Suppl 2():S17-24. PubMed ID: 16271058
[TBL] [Abstract][Full Text] [Related]
18. Methicillin-sensitive Staphylococcus aureus bacteraemia and endocarditis among injection drug users and nonaddicts: host factors, microbiological and serological characteristics.
Ruotsalainen E; Kardén-Lilja M; Kuusela P; Vuopio-Varkila J; Virolainen-Julkunen A; Sarna S; Valtonen V; Järvinen A
J Infect; 2008 Apr; 56(4):249-56. PubMed ID: 18314197
[TBL] [Abstract][Full Text] [Related]
19. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.
Charles PG; Ward PB; Johnson PD; Howden BP; Grayson ML
Clin Infect Dis; 2004 Feb; 38(3):448-51. PubMed ID: 14727222
[TBL] [Abstract][Full Text] [Related]
20. Decreasing incidence of Staphylococcus aureus bacteremia over 9 years: greatest decline in community-associated methicillin-susceptible and hospital-acquired methicillin-resistant isolates.
Khatib R; Sharma M; Iyer S; Fakih MG; Obeid KM; Venugopal A; Fishbain J; Johnson LB; Segireddy M; Jose J; Riederer K
Am J Infect Control; 2013 Mar; 41(3):210-3. PubMed ID: 23040608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
